Company: BLNE
Filing Date: 2025-02-05
Form Type: DEF 14A
Source: 0001493152-25-005006
Chunk: 11

Company: Beeline Holdings, Inc.
Filing Date: 2025-02-05
Form: DEF 14A
Chunk 11
---
 such Proposal and the resulting issuances involve a change of control for Nasdaq purposes with former Beeline shareholders acquiring 82.5% of outstanding common stock and certain preferred stock up to the limit explained on page 29 of this Proxy Statement. Under Nasdaq rules, we are filing a new listing application. In addition to Nasdaq using its qualitative requirements which give it discretion to approve or not approve the new listing application, we must comply with the following new listing requirements:

| ● | $5                              
 million in shareholders’ equity |

| ● | $15                                                          
 million in market value of unrestricted publicly held shares |

| ● | 1                                            
 million in unrestricted publicly held shares |

| ● | 300                                  
 unrestricted round lot shareholders1 |

| ● | Bid          
 price of $4. |

1 Beginning on April 7, 2025, the Series F and F-1 shares may be sold under Rule 144 subject to compliance with the current public information requirements; the Series F and F-1 are also subject to shareholder approval. As soon as the Form 10-K is filed these shares may then be sold under Rule 144 through May 19 thwhen the next Form 10-Q is due. Shares held by insiders are also subject to other Rule 144 compliance requirements including volume limitations. If Nasdaq refuses to approve the new listing application, our common stock will then trade on one of the markets operated by OTC Markets Group, Inc. If that were to occur, our common stock may be less liquid and we may encounter difficulty in raising capital. If our shareholders refuse to approve Proposal 1, we may have no alternative to voluntarily delist form Nasdaq where these adverse consequences outlined in this paragraph would likely occur. SUMMARY This summary highlights selected information from this Proxy Statement and may not contain all the information that is important to you. We urge you to read carefully this entire document, and the documents referenced herein, for a more complete understanding of the Merger Agreement, the Securities, the transactions contemplated therein and the other proposals that will be presented to Eastside shareholders at the Special Meeting. Important Note: With respect to Proposals 1 and 2, shareholders are being asked to approve the issuance of shares of common stock underlying, and the related conversion, exercise and voting rights of, securities issued in or following the Merger, in excess of 20% of the Company’s common stock outstanding as of the closing of the Merger in accordance with Nasdaq rules, including in connection with the Merger, subsequent capital